[HTML][HTML] The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
JR Schwartz, J Ma, J Kamens, T Westover… - Nature …, 2021 - nature.com
Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
JR Schwartz, J Ma, J Kamens, T Westover… - Nature …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Pediatric therapy-related myeloid neoplasms
(tMN) occur in children after exposure to cytotoxic therapy and have a dismal prognosis. The …
(tMN) occur in children after exposure to cytotoxic therapy and have a dismal prognosis. The …
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
JR Schwartz, J Ma, J Kamens, T Westover… - Nature …, 2021 - ideas.repec.org
Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
JR Schwartz, J Ma, J Kamens… - Nature …, 2021 - ui.adsabs.harvard.edu
Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms.
JR Schwartz, J Ma, J Kamens… - Nature …, 2021 - search.ebscohost.com
Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms.
JR Schwartz, J Ma, J Kamens, T Westover… - Nature …, 2021 - europepmc.org
Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
JR Schwartz, J Ma, J Kamens… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
JR Schwartz, J Ma, J Kamens… - Nature …, 2021 - econpapers.repec.org
Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
[HTML][HTML] The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
JR Schwartz, J Ma, J Kamens, T Westover… - Nature …, 2021 - ncbi.nlm.nih.gov
Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …
cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic …